ADA Scientific Sessions 2026
Jun 5–8, 2026New Orleans456 abstracts
Abstracts
200 of 456ADA Scientific Sessions 2026 Abstract
Semaglutide Reduces Multiorgan Proteomic-Based Biological Age across Cohorts
Randomized trial in peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Progressive Failure of Brown Adipose Tissue Remodeling Drives Metabolic Aging
Experiments in miceLipid and ceramide metabolism
ADA Scientific Sessions 2026 Abstract
Metformin Use and Epigenetic Aging in the Million Veteran Program
Cohort study of 13,910 peoplePopulations
ADA Scientific Sessions 2026 Abstract
Role of Immune Microenvironment in Age-Related Decline of Brown Adipose Tissue
Experiments in monkeysImmune response
ADA Scientific Sessions 2026 Abstract
Macrophage OPA1 Prevents Age-Related Metabolic Dysfunction via the mtDNA-STING-STAT6 Pathway
Experiments in miceOPA1
ADA Scientific Sessions 2026 Abstract
Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways
Randomized trial in peopleInterventions
ADA Scientific Sessions 2026 Abstract
HM17321, a CRFR2 Selective UCN2 Analog, Prevents Muscle Loss and Functional Decline in Sarcopenic Mice
Experiments in miceSarcopenia
ADA Scientific Sessions 2026 Abstract
Leukemia Inhibitory Factor Promotes the Adipogenesis of Age-Enriched Adipose Progenitor Cells
Experiments in human cellsMechanisms
ADA Scientific Sessions 2026 Abstract
Apolipoprotein A4 Improves Aging-Related Glucose Homeostasis
Experiments in miceInterventions
ADA Scientific Sessions 2026 Abstract
Lifestyle Intervention and Exercise Reduce Adipose Tissue Senescence in Older Adults with Obesity
Non-randomized trial in 9 peopleLifestyle intervention
ADA Scientific Sessions 2026 Abstract
Senotype Blueprint of the Human Endocrine Pancreas
Study of 13 peopleMechanisms
ADA Scientific Sessions 2026 Abstract
Vascular Age Gap Based on Carotid Intima-Media Thickness as a Marker of Early Vascular Aging in Adults with Type 1 Diabetes and Its Association with Diabetic Complications
Cross-sectional study of 569 peopleCarotid intima-media thickness
ADA Scientific Sessions 2026 Abstract
Quiescence Activates p53 and Promotes Reactive Oxygen Species-Induced DNA Damage Repair in Rejuvenation of Aged Mesenchymal Stem Cells
Experiments in mouse cellsInterventions
ADA Scientific Sessions 2026 Abstract
Mechanisms and Consequences of IL-1β-Mediated Changes in β-Cell Function
Experiments in miceMechanisms
ADA Scientific Sessions 2026 Abstract
Sex-Specific Regulation of Adipose Progenitor Cell Senescence by Lipocalin 2 via Phosphatidic Acid–Dependent mTOR Signaling Pathway
Experiments in mouse cellsmTOR signaling
ADA Scientific Sessions 2026 Abstract
Defining the Role of P21 in β-Cell Senescence Using a Loss-of-Function Model
Experiments in miceCellular senescence
ADA Scientific Sessions 2026 Abstract
Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial
Randomized trial in 48 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Lean Body Mass Polygenic Score Predicts Longitudinal Muscle Loss: Evidence for Faster Decline in Adults with Diabetes
Cohort study of 6,597 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Cardiovascular Health (Life’s Essential 8), Mortality Risk, and Life Expectancy in Type 2 Diabetes and Cardiometabolic Multimorbidity: Insights from UK Biobank
Cohort study of 24,479 peopleCardiometabolic multimorbidity
ADA Scientific Sessions 2026 Abstract
Prediabetes Is Associated with Incident Frailty in Community-Dwelling Older Adults: A Five-Year Time-to-Event Analysis from the Bunkyo Health Study
Cohort study of 1,397 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Association of Randomization to Metformin with Prevalent Cognitive Impairment Syndromes in the Diabetes Prevention Program Outcomes Study
Cohort study of 1,483 peopleMetformin
ADA Scientific Sessions 2026 Abstract
High Frailty among Individuals with Diabetes-Related Multimorbidity in India: Findings from a Nationwide Study
Cross-sectional study of 8,429 peopleMultimorbidity
ADA Scientific Sessions 2026 Abstract
Forty Weeks of Metformin Alters Regional Insulin Sensitivity but Not Mitochondrial Function in Insulin-Resistant Adults
Randomized trial in 40 peopleMetformin
ADA Scientific Sessions 2026 Abstract
Efficacy of a Leucine-Rich EAA, Creatine HCl, and Ca-HMB Stack Coupled with Digital Twin Coaching on Sarcopenia in Type 2 Diabetes: A Double-Blind RCT
Randomized trial in 90 peopleSarcopenia
ADA Scientific Sessions 2026 Abstract
Double Diabetes: A Mediator of Age-Related Cardiovascular Risk in Type 1 Diabetes: A Mediation Analysis of a Large T1D Cohort
Cohort study of 1,266 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
Restoration of Proliferation in Rodent and Human β-Cells by Targeting Senescence
Experiments in mouse cellsInterventions
ADA Scientific Sessions 2026 Abstract
Resistance Exercise Is Associated with Lower Risk of Cardiovascular Events and Mortality across the Cardiovascular–Kidney–Metabolic Syndrome Stages: A Nationwide Cohort Study
Cohort study in peopleCardiovascular-kidney-metabolic syndrome
ADA Scientific Sessions 2026 Abstract
Joint Association of Physical Activity and Sedentary Behavior on Mortality Stratified by Diabetes Mellitus Status: A Pooled Analysis of Six NHLBI Cohorts
Cohort study of 34,988 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Early Vascular Aging in Youth-Onset Type 2 Diabetes: Associations with Glucose and Insulin Responses in the Young at Heart Study
Cohort study in peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Incidence and Predictive Factors of Severe Muscle Loss among Individuals with Prediabetes: A Prospective Cohort Study
Cohort study of 199 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Trajectories of Physical Activity during the Mid- to Late-Life Transition and Cognitive Impairment in Persons with Prediabetes or Type 2 Diabetes
Cohort study of 1,560 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Dementia Progression with GLP-1 Receptor Agonists in People with Type 2 Diabetes and Mild Cognitive Impairment: Retrospective Cohort Study
Cohort study of 1,320 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
GUB-UCN2 as Monotherapy and in Combination with Semaglutide Increases Muscle Mass, Reduces Fat Mass, and Improves Metabolic Outcomes in Aged Diet-Induced Obese Rats
Experiments in ratsSemaglutide
ADA Scientific Sessions 2026 Abstract
Effects of Physical Activity and Diabetes Status on Cognitive Function and Hippocampal Volume: The Bunkyo Health Study
Cross-sectional study of 1,615 peoplePopulations
ADA Scientific Sessions 2026 Abstract
Human Metabolomics Identifies Metabolite Candidates That Attenuate Skeletal Muscle Atrophy
Experiments in mouse cellsMuscle atrophy
ADA Scientific Sessions 2026 Abstract
ANGPTL8 Promotes Endothelial Senescence in Type 2 Diabetes via RTN4R-PI3K/AKT/FOXO3A
Experiments in human cellsPI3K–AKT signaling
ADA Scientific Sessions 2026 Abstract
Glucagon-Like Peptide 1 Receptor Agonists Lower the Risk of Stroke and Vascular Dementia among Individuals with Obesity
Cohort study of 61,880 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
The Relationship between β-Cell Senescence and Incretin Signaling in Type 2 Diabetes
Experiments in cellsGLP-1 and incretin signaling
ADA Scientific Sessions 2026 Abstract
Effect of Semaglutide on COVID-19–Related Complications and All-Cause Death: Pooled Analyses of the SELECT, FLOW, and SOUL Trials
Meta-analysisSemaglutide
ADA Scientific Sessions 2026 Abstract
Low LDL-C Achieved with Lipophilic Statins Is Associated with a Higher Risk of Cognitive Dysfunction
Cross-sectional study in peopleCognitive dysfunction
ADA Scientific Sessions 2026 Abstract
Multimorbidity Phenotypes in Diabetes and Their Association with All-Cause Mortality: A Latent Class Analysis in the UK Biobank
Cohort study of 28,043 peopleMultimorbidity
ADA Scientific Sessions 2026 Abstract
Clinical Frailty Is a Major Determinant of Long-Term Survival in People with Diabetic Foot Ulcer Disease
Cohort study of 283 peopleDiabetic foot ulcer
ADA Scientific Sessions 2026 Abstract
Longitudinal Validation of a Retinal AI Score for Cardiovascular Risk Monitoring: Validation in Korean and UK Populations
Cohort study of 18,084 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Association between C-Reactive Protein–Triglyceride–Glucose Index and New-Onset Chronic Disease Incidence and Mortality: Evidence from Multinational Cohorts
Cohort study of 5,366 peopleC-reactive protein-triglyceride-glucose index
ADA Scientific Sessions 2026 Abstract
Multiorgan Magnetic Resonance–Based Imaging Improves Risk Stratification and Supports Treatment Allocation in Individuals with Clinical Obesity
Cohort study of 23,087 peopleObesity
ADA Scientific Sessions 2026 Abstract
Molecular Risk Scores Enhance Type 2 Diabetes (T2D) Prediction beyond Hemoglobin A1c (HbA1c) and Body Mass Index (BMI) across Diverse Clinical Contexts
Cohort study in peopleHbA1c
ADA Scientific Sessions 2026 Abstract
Uncertainty-Calibrated Prediction of Cardiovascular–Kidney–Liver–Metabolic Disease Using Clinical Biomarkers and Plasma Proteomics
Cohort study of 49,312 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Multimorbidity and Mortality in U.S. Adults with Diabetes: The Role of Age and Diabetes Duration
Cohort study in peopleMultimorbidity
ADA Scientific Sessions 2026 Abstract
Proteomics-Based Molecular Adiposity and Risk of Type 2 Diabetes in Diverse Population
Cohort study of 45,226 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
High Sensitivity Proteomics for Predicting Dementia in Older Adults with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Cohort study of 487 peopleDementia
ADA Scientific Sessions 2026 Abstract
Cardiovascular–Kidney–Metabolic Syndrome and Risk of Mild Cognitive Impairment and Dementia in Men and Women: Findings from the UK Biobank and All of Us
Cohort study of 109,137 peopleVascular dementia
ADA Scientific Sessions 2026 Abstract
Associations of Total, Plant-Based, and Animal-Based Low-Carbohydrate Diets with Mortality in Individuals with Stage 3–4 CKM Syndrome
Cohort study in peoplePopulations
ADA Scientific Sessions 2026 Abstract
Machine-Learning Modeling for T2DM Prediction in over 3 Million Adults
Cohort study in peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
GLP-1 Receptor Agonists and Cardiovascular Events in Adults with Obesity and Autoimmune Disease: A Target Trial Emulation
Cohort study of 13,204 peopleAutoimmune disease
ADA Scientific Sessions 2026 Abstract
Systematic Identification of High Risk for Type 2 Diabetes in People with Mental Illness Based on Electronic Health Record Data and Machine Learning
Computational studyPsychiatric disorder
ADA Scientific Sessions 2026 Abstract
Age at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease (CAD) Incidence in Women with Type 1 Diabetes (T1D)
Cohort study of 121 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
Prescribing Trends and Comparative Risk of Type 2 Diabetes Progression in Prediabetes by Antihyperglycemic Drug Class
Cohort study of 32,520 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Development and Predictive Performance of the Sensory & Social Neglect Index for Metabolic and Cognitive Decline
Cross-sectional study of 4,573 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Molecular Basis of Type 2 Diabetes Prevention by Semaglutide in SELECT
Randomized trial in 7,209 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Wearables-Derived Physical Activity Is Independently Associated with Lower Odds of Type 2 Diabetes in the All of Us Research Program
Cohort study of 13,482 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Comparing Seven Adiposity Indexes in Their Ability to Predict Type 2 Diabetes Risk across Five U.S. Cohorts
Cohort study in peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Integrating Lipoprotein(a) with Retinal Imaging Biomarkers for Cardiovascular Risk Assessment: UK Biobank Analysis
Cohort study of 50,475 peopleLipoprotein
ADA Scientific Sessions 2026 Abstract
Development and Validation of an Optimized Diabetes Screening Strategy Integrating Fasting Capillary Blood Glucose with the Chinese Diabetes Risk Score in Primary Care Settings
Cohort study of 41,156 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Routine Blood Biomarkers Predict Five-Year Risk of Type 2 Diabetes in Adults without Diabetes
Cohort study of 80,000 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Concordance between QDiabetes and A Literature-Based Methodology Estimating 10-Year Type 2 Diabetes Risk in a Simulated Population
Computational studyType 2 diabetes
ADA Scientific Sessions 2026 Abstract
A Novel Dual-Endpoint Model to Simultaneously Predict Risks of Type 2 Diabetes and Cardiovascular Disease in Prediabetes
Cohort study of 46,828 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Long-Term Effects of Metformin and Lifestyle Interventions on Ankle-Brachial Index in the Diabetes Prevention Program Outcomes Study (DPPOS)
Randomized trial in 3,234 peopleLifestyle intervention
ADA Scientific Sessions 2026 Abstract
Adherence to the EAT-Lancet Diet and Incident Diabetes: Results from the Atherosclerosis Risk in Communities (ARIC) Study
Cohort study of 12,730 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Can 14 Days of Metformin Prevent Post-COVID Diabetes?
Randomized trial in 1,136 peopleMetformin
ADA Scientific Sessions 2026 Abstract
CGM-Derived Measures in Relation to 10-Year CVD Risk in Adults without Diabetes
Cohort study of 1,374 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Metabolomic Signature of Socioeconomic Position and Incident Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos
Cohort study of 5,097 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Life’s Essential 8 and Mortality in U.S. Adults with Diabetes: Greater Risk Reduction Compared with Those without Diabetes
Cohort study of 20,231 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Equity-Sensitive Prediabetes Screening: Discordant Phenotypes across HbA1c, FPG, and OGTT in NHANES 2005–2016
Cross-sectional study of 11,091 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
The Mediating Effect of Renal Function on the Association between Life’s Essential 8 and Cognitive Function
Cross-sectional study of 2,196 peopleKidney
ADA Scientific Sessions 2026 Abstract
Reduction in Incident Type 2 Diabetes with National Diabetes Prevention Program/Intensive Lifestyle Intervention: Results from the Reality Research Network
Cohort study in peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Effect of Different Treatment Durations of Sodium–Glucose Cotransporter 2 Inhibitor on Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Target Trial Emulation Study
Cohort study in peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Comparison of Surrogate Indexes of Insulin Resistance as Predictors of Diabetes: Analysis of Five U.S. Cohorts
Cohort study of 3,508 peopleInsulin
ADA Scientific Sessions 2026 Abstract
MicroRNAs Have Potential Utility for Predicting Risk for Type 2 Diabetes in the Context of Underlying Genetic Characteristics
Cohort study of 854 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Performance of Insulin Resistance Markers in Predicting 10-Year Cardiovascular Risk Using the Framingham Score: An NHANES-Based Study
Cross-sectional study in peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Real-World Effectiveness of Novel Antidiabetic Medications on Cardiovascular Outcomes among Medicare Beneficiaries by Race
Cohort study of 616,297 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Association of Newer Glucose-Lowering Drugs with Incident Parkinsonian Disorders in Older Adults with REM Sleep Behavior Disorder and Type 2 Diabetes
Cohort study of 148 peopleParkinsonism
ADA Scientific Sessions 2026 Abstract
Cardiometabolic–Kidney Staging and Mortality Outcomes in South Asians
Cohort study of 17,430 peopleKidney
ADA Scientific Sessions 2026 Abstract
Multimorbidity Phenotypes in Diabetes and Their Association with 10-Year Dementia Risk: A Latent Class Analysis in the UK Biobank
Cohort study of 28,043 peopleDementia
ADA Scientific Sessions 2026 Abstract
Prediabetes Prevalence and Diabetes Incidence according to Different Prediabetes Definitions: Implications for Diabetes Prevention
Cohort study in peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Menopausal Hormonal Status and Estradiol Use Modulate Semaglutide-Associated Weight Loss in Women: Analyses from STEP1 and SELECT
Randomized trial in 17,604 peopleEstradiol
ADA Scientific Sessions 2026 Abstract
SGLT2 Inhibitor Attenuates eGFR Slope in Type 2 Diabetes with UACR <30 mg/gCr
Cohort study of 954 peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Individualized Care Pathways vs. Usual Care to Reduce Conversion Rates from Prediabetes to Diabetes
Cohort study in peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Associations between MRI-Derived Visceral Adipose Tissue and Incident Cardiometabolic Outcomes in a Large Population Cohort
Cohort study of 75,331 peopleVisceral adipose tissue
ADA Scientific Sessions 2026 Abstract
Clinically Significant Changes in Body Composition with Treatment of Obesity in Older Adults, 65+, with and without Diabetes
Cohort study of 112 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Enzymatic Quantification of 2-Hydroxybutyrate: A Dynamic Biomarker for Predicting Glycemic Dysfunction
Cohort study of 772 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Divergent Risk Profiles of Diabetes Progression in Lean and Obese Prediabetes
Cohort study of 297 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Effectiveness and Safety of SGLT2i, GLP-1RA, and DPP-4i in Adults with T2D at Low-to-Moderate Cardiovascular Risk: An International Cohort Study
Cohort study in peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Diagnostic Value of Body Fat Percentage vs. Body Mass Index for Cardiometabolic Risk Identification in Medical Students of National University of Córdoba, Argentina
Cross-sectional study of 152 peopleBody fat percentage
ADA Scientific Sessions 2026 Abstract
Coffee Intake Timing, Metabolomics, and Diabetes: A Prospective Study in the Hispanic Community Health Study/Study of Latinos (HCHSL/SOL)
Cohort study of 7,091 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Association of Life Events, Social Support, and Family Functioning with Risk of Developing Diabetes and the Mediating Effects of Body Mass Index (BMI) and Waist Circumference (WC)
Cohort study of 3,234 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Cardiovascular Outcomes Associated with GLP-1 Receptor Agonist Use among Adults with Type 1 Diabetes and Overweight or Obesity: A Target Trial Emulation Using Real-World EHR Data
Cohort study of 102,676 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Primary Prevention of Cardiovascular Events in Type 2 Diabetes
Cohort study of 648,505 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Asian Ancestry and Higher Predicted 10-Year Type 2 Diabetes Risk: Greater Insulin Resistance and Lower β-Cell Function
Cross-sectional study of 448 peoplePopulations
ADA Scientific Sessions 2026 Abstract
Emulation of a Trial of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (DELIVER)
Cohort study of 8,162 peopleDapagliflozin
ADA Scientific Sessions 2026 Abstract
Cardiovascular (CVD) Risk Factors during the Menopausal Transition among Women with Type 1 Diabetes (T1D)
Cohort study of 243 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
Does the Inclusion of Lipoprotein(a) Levels Alter Cardiovascular Risk Assessment in Adults with Type 1 Diabetes Assessed Using the Steno T1 Risk Engine? Secondary Data Analysis from the InLipoDiab1 Cohort
Cohort study of 122 peopleLipoprotein
ADA Scientific Sessions 2026 Abstract
Prediabetes and Cognitive Impairment: The Influence of Social Risk Factors, HRS 2006–2016
Cohort study of 11,943 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Prediabetes Stage and Kidney Function Decline in Nondiabetic Adults: A Metabolic Liver–Kidney Link?
Cohort study of 3,940 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Where Fat Is Stored Matters More than How Much: A Large-Scale Population-Based Study Integrating DXA Phenotyping and Causal Inference
Cohort study of 3,067 peoplePopulations
ADA Scientific Sessions 2026 Abstract
Metabolic Effects of Active Breaks to Sitting vs. Continuous Walking in Adults with Prediabetes: Preliminary Results from the BURST2D Study
Randomized trial in 48 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Metabolomic Analysis Reveals That Prediabetes Subgroups Have Different Likelihoods of T2D Onset: A Definition, Etiology, and Function: Integration to Enhance T2D Treatment (DEFINE-T2D) Consortium Analysis
Cohort study of 5,567 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Multimorbidity among Individuals with Diabetes (MAID) in India: A State-Level Analysis of a National Study
Cross-sectional study of 8,714 peopleMultimorbidity
ADA Scientific Sessions 2026 Abstract
Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Type 1 Diabetes: A Target Trial Emulation Study
Cohort study of 17,850 peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Association between Diabetes Mellitus Incidence and Stressful Life Events, Perceived Stress, and Problematic Anger among Post 9/11 Military Veterans in the Millennium Cohort Study
Cohort study of 36,059 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
A Randomized Trial of Shared-Decision Making for Type 2 Diabetes Prevention in Women with a History of Gestational Diabetes
Randomized trial in 247 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Spousal Influences on Incident Type 2 Diabetes: A Longitudinal Study of South Asians
Cohort study of 2,775 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Sex-Specific Cognitive Responses to Prolonged Fasting in Healthy Adults: A Pilot Within-Subject Study
Randomized trial in 9 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Fragility Fracture Risk among Patients with Type 2 Diabetes Initiating Treatment with GLP-1 Receptor Agonists vs. Sulfonylureas
Cohort study of 387,102 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
The Clinical Outcomes of Preclinical and Clinical Obesity across Multiple Cohorts
Cohort study in peopleClinical obesity
ADA Scientific Sessions 2026 Abstract
Cumulative Childbirths Show a U-shaped Association with Metabolic Syndrome in Midlife Women: The Bogalusa Heart Study
Cohort study of 1,132 peopleMetabolic syndrome
ADA Scientific Sessions 2026 Abstract
Cardio–Renal–Metabolic Multimorbidity in India: Findings from a Large Community-Based Study
Cross-sectional study of 11,017 peopleKidney
ADA Scientific Sessions 2026 Abstract
Comparative Efficacy of Obesity Treatments on Major Adverse Cardiovascular Events, Heart Failure, and All-Cause Mortality in Adults with Overweight and Obesity: A Systematic Review and Network Meta-analysis
Meta-analysis of randomized trialsMajor adverse cardiovascular events
ADA Scientific Sessions 2026 Abstract
Frailty-Guided Glycaemic Management in an Elderly Diabetic Population Based in the United Kingdom
Cohort study of 489 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Ethnic Disparities in the Prevalence and Risk Factors of Prediabetes and Diabetes in Australian Primary Care
Cohort study of 60,887 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Psoas Muscle Area Is a Useful Indicator of Muscle Mass in Older Men with Type 2 Diabetes: A Retrospective Study
Cross-sectional study of 101 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Longitudinal vs. Single Timepoint Proteomics Identify Novel and Distinct Diabetes Biomarkers in a Multiethnic Cohort
Cohort study of 5,322 peopleIncident diabetes
ADA Scientific Sessions 2026 Abstract
Association of E-sdLDL-C with Disease Progression and Mortality Risk among Individuals with CKM Syndrome
Cohort study of 16,167 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Unraveling the Metabolic–Cardiovascular Disease Nexus: An Epidemiological Network Analysis Identifies Central Indicators
Cohort study of 4,066 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Fracture Risk with Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes: A Target Trial Emulation
Cohort study of 13,664 peopleSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Per- and Polyfluoroalkyl Substances Exposure, Blood Metabolome, and Risk of Incident Type 2 Diabetes in Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Cohort study of 7,960 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
CT-388, a cAMP Signal-Biased GLP-1/GIP Receptor Agonist, Achieves Clinically Meaningful Weight Loss in People With Overweight/Obesity: A 48-Week Phase 2 Study
Randomized trial in 467 peopleObesity
ADA Scientific Sessions 2026 Abstract
Semaglutide and Obstructive Sleep Apnea (OSA): A Post Hoc Analysis from SELECT
Randomized trial in 2,550 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Dual GLP-1/GIP Receptor Agonist HDM1005 in Obese Participants without Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Randomized trial in 243 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Type 2 Diabetes Remission Rate and Change in Medication Burden after 12 Months of Intermittent Fasting
Randomized trial in 57 peopleIntermittent fasting
ADA Scientific Sessions 2026 Abstract
Effects of a Camp-Style Lifestyle Modification Program on Diabetes Prevention in Rural Women with Prior GDM
Randomized trial in 108 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Assessing Advanced Glycation Endproducts Using a Wearable Health Monitoring Device
Cross-sectional study of 200 peopleContinuous Glucose Monitoring
ADA Scientific Sessions 2026 Abstract
Evaluating Both Fasting and 1-Hour Glucose Enhances Cardiometabolic Risk Stratification by the 1-Hour Oral Glucose Tolerance Test
Cross-sectional study of 712 peopleGlucose
ADA Scientific Sessions 2026 Abstract
The Addition of the AHA PREVENT Risk Model to NT-proBNP–Based Screening in Patients with Diabetes and Risk Factors for Heart Failure: An Exploratory Analysis of TARTAN-HF
Randomized trial in 335 peopleNT-proBNP
ADA Scientific Sessions 2026 Abstract
Body Mass Index and Blood Pressure Changes During and After Antiobesity Medication Use
Cohort study of 1,642 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Cardiometabolic Effects of Semaglutide in OASIS 4 Participants by BMI Class
Randomized trial in 119 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Feasibility of a Salon-Based Diabetes Risk Screening and Prevention Program Referral Intervention
Non-randomized trial in 20 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Increased Risk for Dementia in the Setting of Traumatic Brain Injury (TBI) in Type 2 Diabetes (T2D) Patients
Cohort study of 320,650 peopleDementia
ADA Scientific Sessions 2026 Abstract
Overall and Site-Specific Tumor Incidence and Prevalence Differ across Prediabetes Subphenotypes
Cohort study of 2,260 peopleTumor
ADA Scientific Sessions 2026 Abstract
Circulating N-lactoyl Amino Acids, GCKR Variant, and Risk of Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos
Cohort study of 13,814 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Evaluating Polygenic Risk Scores for Body Mass Index across Diverse Populations and Contexts
Cohort study of 501,247 peopleBody mass index
ADA Scientific Sessions 2026 Abstract
GLP-1 Receptor Agonists and Diabetic Foot Ulcer Risk: A Meta-analysis
Meta-analysis of studies in peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Metabolic Response to Oral Semaglutide in Adults with Obesity—Weight Loss and Beyond: The GAROS Prospective Study
Non-randomized trial in 1,100 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
Randomized trial in 48 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Imeglimin and Nicotinamide Mononucleotide Ameliorate High Glucose–Induced Mitochondrial Dysfunction and Senescence in Schwann Cells
Experiments in mouse cellsNicotinamide mononucleotide
ADA Scientific Sessions 2026 Abstract
The Effect of Prolonged Fasting and Nutritional Ketosis on Cognition
Randomized trial in 7 peopleFasting
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Semaglutide by Race and Ethnicity in the SELECT Trial
Randomized trial in peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Early Lifestyle Changes after a Pharmacist-Led Diabetes Prevention Intervention in the New Orleans Hospitality Workforce
Non-randomized trial in 40 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Effect of Subcutaneous Semaglutide on Cardiorenal Outcomes across Type 2 Diabetes Subtypes: SUSTAIN 6 Post Hoc Analysis
Randomized trial in 3,251 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
GLP-1R in JBMMSCs Suppressed Jaw Bone Osteoporosis via Modulating PKA/STAT3/TET3/SHP2/ß-catenin Signaling–Induced Osteoblast Differentiation
Experiments in ratsBones and joints
ADA Scientific Sessions 2026 Abstract
Fracture Risk Associated with Tirzepatide: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Evidence
Meta-analysis of studies in peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
Comparing Major Adverse Kidney Events (MAKE) among New Users of Oral Semaglutide (SEMA) vs. Select Oral Antidiabetic Medications (ADMs) among U.S. Adults with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
Cohort study of 66,056 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Serum Proteomics Suggest Novel Mechanisms of Action of Semaglutide in Reducing the Risk of MACE in the SELECT Trial
Randomized trial in 9,461 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Cost-Effectiveness of Bariatric Surgery for Preventing Diabetes in U.S. Adults with Prediabetes and Severe Obesity: A Simulation Study
Computational studyBariatric surgery
ADA Scientific Sessions 2026 Abstract
Ertugliflozin Mitigates Blood Pressure Increments during a High-Sodium Diet in People with Type 2 Diabetes
Randomized trial in 34 peopleErtugliflozin
ADA Scientific Sessions 2026 Abstract
Long-Term Impact of Early Oral Antidiabetic Therapy on Insulin Secretion Phases in Individuals with Prediabetes (PreDM): Insights from Hyperglycemic Clamp Studies
Non-randomized trial in 60 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Effects of SGLT2 Inhibitors on Cardiac Arrhythmias: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomized trialsSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Durable Cardiometabolic Effects of Utreglutide in Metabolic Dysfunction–Associated Steatotic Liver Disease Patients with Nondiabetic and Prediabetic Status
Randomized trial in 48 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Assessing the Impact of a Plant-Based Diet for Diabetes Prevention: A Pilot Study
Non-randomized trial in 6 peoplePlant-based diet
ADA Scientific Sessions 2026 Abstract
Once-Monthly Zovaglutide (ZT002) in Adults with Overweight or Obesity and Prediabetes: A Phase 2 Subgroup Analysis
Randomized trial in 116 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Unidos en Salud: Using a Mobile Unit for Implementing Diabetes Screening in Rural Latino Communities
Non-randomized trial in 186 peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Type 2 Diabetes Heterogeneity and Incident Dementia Risk Compared with Adults without Diabetes
Cohort study of 878,094 peopleVascular dementia
ADA Scientific Sessions 2026 Abstract
Harmine and Exendin-4 Combination Attenuates Human β-Cell Senescence
Experiments in human cellsExenatide
ADA Scientific Sessions 2026 Abstract
Cardiovascular Disease Risk Prediction in Type 1 Diabetes over 30 Years
Cohort study of 1,311 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
A Trispecific GLP-1/GIP/hGH Receptor Agonist Targeting Activin Type II Receptor Drives Selective Fat Mass Reduction
Experiments in miceGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Twenty-Year Glycemia Trajectories and Risk for Cognitive Impairment (CI) in Adults with Prediabetes or Type 2 Diabetes (T2D) in the Diabetes Prevention Program Outcomes Study (DPPOS)
Cohort study of 1,682 peopleAmnestic mild cognitive impairment
ADA Scientific Sessions 2026 Abstract
Lean Mass Effects of Anti-GDF8 (Trevogrumab) ± Anti-Activin A (Garetosmab) in People Living with Obesity Treated with Semaglutide with or without Low Lean Mass at Baseline
Randomized trial in 599 peopleObesity
ADA Scientific Sessions 2026 Abstract
Increasing Energy Expenditure with the Liver-Targeted Mitochondrial Protonophore TLC-6740 Enhances Weight Loss and Metabolic Benefits in Combination with Tirzepatide in Obesity: A Phase 2a Study
Randomized trial in 55 peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
Long-Term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study (DPPOS)
Randomized trial in 1,666 peopleMetformin
ADA Scientific Sessions 2026 Abstract
Heterogeneity in Rates of Mortality among Subtypes of Prediabetes
Cohort study of 14,568 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Prediabetes Screening and Metformin Use among Adults Taking Antipsychotic Medications in Primary Care
Cohort study of 8,240 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
Risk of Developing Cardiorenal Complications in People Living with Overweight or Obesity, with vs. without T2D
Cohort study in peopleOverweight or obesity
ADA Scientific Sessions 2026 Abstract
Ertugliflozin Reduces Blood Pressure and EGFR during Both Moderate- and High-Sodium Intake in People with Type 2 Diabetes.
Randomized trial in 34 peopleErtugliflozin
ADA Scientific Sessions 2026 Abstract
Tirzepatide: Effect on Insulin Resistance and Human Fat Cells
Randomized trial in 30 peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
The Role of Diabetes in the Relationship between Muscle Strength and Atrial Fibrillation
Cohort study of 98,006 peopleAtrial fibrillation
ADA Scientific Sessions 2026 Abstract
Changes in Body Composition During and After Weight Loss with Tirzepatide
Randomized trial in 63 peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
Exploring Semaglutide's Effect on the ASCVD-Related Proteomic Signature and Their Prediction of MACE in SELECT
Randomized trial in 10,878 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Heterogeneity of Treatment Effect of Glucagon-Like Peptide 1 Receptor Agonists for Secondary Prevention of Cardiovascular Events in Type 2 Diabetes
Cohort study of 405,952 peopleGLP-1 receptor agonists
ADA Scientific Sessions 2026 Abstract
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
Randomized trial in 40 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
High-Dose Semaglutide Is Associated with Preservation of Kidney Function in People Living with Obesity without Diabetes
Randomized trial in 1,005 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Tirzepatide Induced Cardiometabolic Transformation in Indian Patients with Obesity: A Prospective Cohort Study
Study of 91 peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
Individualized Slope Analysis: Optimizing Reno-Protective Pillars of Therapy
Study of 75 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Early Metabolic and Hepatic Benefits of Tirzepatide in Indian Adults with Type 2 Diabetes: Insights from Real-World Practice
Cohort study of 71 peopleTirzepatide
ADA Scientific Sessions 2026 Abstract
Longitudinal Dynamics of Cardiometabolic Parameters in a MASH Population Stratified by Baseline Glycemia and Treated with Semaglutide: Post Hoc Insights from the ESSENCE Trial Part 1
Randomized trial in 800 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Are We Catching T2DM Early Enough? Retrospective Study of Medical Student Screening Program for Prediabetes/T2DM in an Underserved Population Demonstrates Gaps in Diagnosis in South Carolina
Cohort study of 868 peoplePrediabetes
ADA Scientific Sessions 2026 Abstract
PCSK9 Inhibitors Are Associated with a Lower Risk of Incident Diabetes: A Global Real-World Analysis
Cohort study of 27,025 peoplePCSK9 inhibitors
ADA Scientific Sessions 2026 Abstract
Renal Function Markers and Pancreatic Cancer Risk in Patients with Type 2 Diabetes: Findings from the Tianjin Diabetes and Health Cohort Study
Cohort study of 249,255 peoplePancreatic cancer
ADA Scientific Sessions 2026 Abstract
ACCESS Trial: Dose-Ranging Evaluation of Aleniglipron, an Oral Small Molecule Nonpeptide GLP-1RA, Demonstrates Meaningful Weight Reductions in People Living with Obesity and Overweight
Randomized trial in 230 peopleOverweight
ADA Scientific Sessions 2026 Abstract
Semaglutide Improves Tissue-Specific Insulin Action and Reduces Liver Fat in Type 2 Diabetes with Spinal Cord Injury
Non-randomized trial in 5 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Randomized trial in 185 peopleOverweight
ADA Scientific Sessions 2026 Abstract
Physical Activity Is Associated with Less Lean Mass Loss than Caloric Restriction in People with Diabetes Undergoing Weight Loss
Cohort study of 311 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Baseline Clinical and Proteomic Predictors of Glycemic Deterioration in SELECT
Cohort study of 6,578 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Effects of Supervised Vigorous Exercise on Tissue-Specific Insulin Resistance in South Asian and Nordic Women with Previous Gestational Diabetes
Non-randomized trial in 22 peopleInsulin resistance
ADA Scientific Sessions 2026 Abstract
Cardiometabolic Risk Trajectories On and After Antiobesity Medication Use
Cohort study of 20,112 peopleInterventions
ADA Scientific Sessions 2026 Abstract
Nativity and English Language Use in Relation to Undiagnosed and Diagnosed Diabetes in U.S. Adults
Cross-sectional study in peopleDiabetes mellitus
ADA Scientific Sessions 2026 Abstract
Rate of Age-Related EGFR Decline Differs by Insulin Dose in Type 1 Diabetes
ADA Scientific Sessions 2026 Abstract
Macrovascular Outcomes in Aging Patients with Type 2 Diabetes Mellitus
Cohort study of 186,102 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Older Adults with Prediabetes or Type 2 Diabetes Experience Poor Recovery of Muscle Power and Torque but Not Volume following 10 Days of Bed Rest
Non-randomized trial in 39 peopleMuscle
ADA Scientific Sessions 2026 Abstract
Effect of Mazdutide on Kidney Function in Adults with Obesity or Overweight
Randomized trial in 179 peopleMazdutide
ADA Scientific Sessions 2026 Abstract
Low Hand Grip Strength Is Not Limited to Ageing: Evidence from Young Indian Adults
Cohort study of 292 peopleHand grip strength
ADA Scientific Sessions 2026 Abstract
Sex-Specific Mechanisms of Weight Loss-Induced Prediabetes Remission
Cohort study of 298 peoplePrediabetes